FDA autism drug move sparks frenzy, but data lags behind – Reuters

  1. FDA autism drug move sparks frenzy, but data lags behind  Reuters
  2. AAP does not recommend routine use of leucovorin in children with autism  Contemporary Pediatrics
  3. US pediatrician group recommends against routine use of drug for autism  MarketScreener
  4. Medical group advises against leucovorin for autism  pharmaphorum
  5. Doctors’ warning over $2.50 autism pill that has transformed lives  Daily Mail

Continue Reading